Lidocaine injection for subdermal etonogestrel in contraception

Provenance

Written by SPS and the College of Sexual and Reproductive Healthcare (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.

August 2025 – note the Faculty of Sexual and Reproductive Healthcare (FSRH) has now changed its name to the College of Sexual and Reproductive Healthcare (CoSRH). Some web pages and CoSRH documents will continue to display the FSRH name; where you see FSRH, this refers to CoSRH. All weblinks are still active.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).

• Lidocaine for Implant National PGD template V3.0 accessible 04.26Opens in a new window · Word · 72 KB

More reproductive health PGD templates

Other templates in this area are available.

• Etonogestrel (e.g. Nexplanon®) implant for contraception
• Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception
• Medroxyprogesterone acetate (DMPA) SC injection for contraception
• Combined hormonal contraceptive transdermal patch
• Combined hormonal contraceptive vaginal ring
• Progestogen only pill (POP) for contraception
• Medroxyprogesterone acetate (DMPA) IM injection for contraception
• Combined oral hormonal contraceptive (COC) in reproductive health
• Ulipristal acetate 30mg tablets for emergency contraception
• Levonorgestrel 1500 microgram tablets for emergency contraception
• Lidocaine plus prilocaine cream for IUD insertion or removal
• Lidocaine 10mg/ml spray for IUD insertion or removal
• Copper Intrauterine Device (Cu-IUD)

All PGD templates

Update history